For example, miR-21 facilitates breast cancer progression and metastasis by inhibiting tumor suppressor genes such as PTEN and PDCD4, which in turn activate the PI3K/AKT and MEK/ERK signaling pathways 38-41. This evidence concerns the gene AKT1 and breast cancer.